Patient-Provider Communication and Medication Adherence
MEDCHAT
Racial Differences in Patient-Provider Communication and Medication Adherence
2 other identifiers
observational
114
1 country
1
Brief Summary
The purpose of this study is to understand how communication between African American and white patients with high blood pressure and his/her primary care provider effects whether a patient decides to take their high blood pressure medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2011
CompletedFirst Posted
Study publicly available on registry
September 2, 2011
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2015
CompletedOctober 18, 2017
October 1, 2017
1.1 years
August 31, 2011
October 16, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medication Adherence
Medication adherence will be assessed as a continuous variable with the Medication Event Monitoring System (MEMS) and calculated as the percent of prescribed doses removed by the patient during the 3-month stud
3-months
Secondary Outcomes (1)
patient-provider communication
Baseline
Study Arms (1)
No treatment
African American/Black and Caucasian/White patients with hypertension
Eligibility Criteria
Patients will be recruited from Primary Care Clinics in New York City
You may qualify if:
- self-identification as black/African American or white/Caucasian
- Receiving care in the Bellevue Hospital Ambulatory Care Practice from the same primary care provider for at least 3 months;
- Diagnosed with hypertension (ICD: # 401-401.9)
- Taking at least one antihypertensive medication;
- Age18 years or older
- Fluent in English
You may not qualify if:
- Unable to give informed consent
- Refuse to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bellevue Hospital Ambulatory Care Practive
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antoinette Schoenthaler, EdD
NYU School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2011
First Posted
September 2, 2011
Study Start
March 1, 2014
Primary Completion
April 22, 2015
Study Completion
April 22, 2015
Last Updated
October 18, 2017
Record last verified: 2017-10